PV
Peter J. Van Veldhuizen

Publications (1)

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)
Article scientifique · 2018

Domaines principaux

Sciences de la santé1

Statistiques

Consultations3
Téléchargements0